190 related articles for article (PubMed ID: 38099997)
1. Assessment of Prostate and Bladder Cancer Genomic Biomarkers Using Artificial Intelligence: a Systematic Review.
Bazarkin A; Morozov A; Androsov A; Fajkovic H; Rivas JG; Singla N; Koroleva S; Teoh JY; Zvyagin AV; Shariat SF; Somani B; Enikeev D
Curr Urol Rep; 2024 Jan; 25(1):19-35. PubMed ID: 38099997
[TBL] [Abstract][Full Text] [Related]
2. Applications of artificial intelligence in urologic oncology.
Pak S; Park SG; Park J; Cho ST; Lee YG; Ahn H
Investig Clin Urol; 2024 May; 65(3):202-216. PubMed ID: 38714511
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction.
Borhani S; Borhani R; Kajdacsy-Balla A
Crit Rev Oncol Hematol; 2022 Mar; 171():103601. PubMed ID: 35065220
[TBL] [Abstract][Full Text] [Related]
4. Current and future applications of machine and deep learning in urology: a review of the literature on urolithiasis, renal cell carcinoma, and bladder and prostate cancer.
Suarez-Ibarrola R; Hein S; Reis G; Gratzke C; Miernik A
World J Urol; 2020 Oct; 38(10):2329-2347. PubMed ID: 31691082
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature.
Kluth LA; Black PC; Bochner BH; Catto J; Lerner SP; Stenzl A; Sylvester R; Vickers AJ; Xylinas E; Shariat SF
Eur Urol; 2015 Aug; 68(2):238-53. PubMed ID: 25709027
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence in bladder cancer prognosis: a pathway for personalized medicine.
Pinar U; Pradere B; Roupret M
Curr Opin Urol; 2021 Jul; 31(4):404-408. PubMed ID: 33882561
[TBL] [Abstract][Full Text] [Related]
7. The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches.
Alarcón-Zendejas AP; Scavuzzo A; Jiménez-Ríos MA; Álvarez-Gómez RM; Montiel-Manríquez R; Castro-Hernández C; Jiménez-Dávila MA; Pérez-Montiel D; González-Barrios R; Jiménez-Trejo F; Arriaga-Canon C; Herrera LA
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):431-443. PubMed ID: 35422101
[TBL] [Abstract][Full Text] [Related]
8. Bladder Cancer and Artificial Intelligence: Emerging Applications.
Laurie MA; Zhou SR; Islam MT; Shkolyar E; Xing L; Liao JC
Urol Clin North Am; 2024 Feb; 51(1):63-75. PubMed ID: 37945103
[TBL] [Abstract][Full Text] [Related]
9. Exploring alternative approaches to precision medicine through genomics and artificial intelligence - a systematic review.
Mumtaz H; Saqib M; Jabeen S; Muneeb M; Mughal W; Sohail H; Safdar M; Mehmood Q; Khan MA; Ismail SM
Front Med (Lausanne); 2023; 10():1227168. PubMed ID: 37849490
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.
Catto JW; Linkens DA; Abbod MF; Chen M; Burton JL; Feeley KM; Hamdy FC
Clin Cancer Res; 2003 Sep; 9(11):4172-7. PubMed ID: 14519642
[TBL] [Abstract][Full Text] [Related]
12. Artificial Intelligence in Magnetic Resonance Imaging-based Prostate Cancer Diagnosis: Where Do We Stand in 2021?
Suarez-Ibarrola R; Sigle A; Eklund M; Eberli D; Miernik A; Benndorf M; Bamberg F; Gratzke C
Eur Urol Focus; 2022 Mar; 8(2):409-417. PubMed ID: 33773964
[TBL] [Abstract][Full Text] [Related]
13. What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments?
Zhao LT; Liu ZY; Xie WF; Shao LZ; Lu J; Tian J; Liu JG
Mil Med Res; 2023 Jun; 10(1):29. PubMed ID: 37357263
[TBL] [Abstract][Full Text] [Related]
14. Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes.
Mitchell KA; Williams H
Urol Oncol; 2022 Apr; 40(4):126-132. PubMed ID: 31239186
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer.
Chu TN; Wong EY; Ma R; Yang CH; Dalieh IS; Hung AJ
Curr Urol Rep; 2023 May; 24(5):231-240. PubMed ID: 36808595
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis.
Laukhtina E; Shim SR; Mori K; D'Andrea D; Soria F; Rajwa P; Mostafaei H; Compérat E; Cimadamore A; Moschini M; Teoh JY; Enikeev D; Xylinas E; Lotan Y; Palou J; Gontero P; Babjuk M; Witjes JA; Kamat AM; Roupret M; Shariat SF; Pradere B;
Eur Urol Oncol; 2021 Dec; 4(6):927-942. PubMed ID: 34753702
[TBL] [Abstract][Full Text] [Related]
17. A Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers.
Huang W; Randhawa R; Jain P; Hubbard S; Eickhoff J; Kummar S; Wilding G; Basu H; Roy R
JCO Clin Cancer Inform; 2022 Feb; 6():e2100131. PubMed ID: 35192404
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers.
Ahmed ME; Todenhöfer T; Karnes RJ; Seiler R
Eur Urol Focus; 2022 May; 8(3):663-666. PubMed ID: 35843864
[TBL] [Abstract][Full Text] [Related]
19. Urinary Volatiles and Chemical Characterisation for the Non-Invasive Detection of Prostate and Bladder Cancers.
Tyagi H; Daulton E; Bannaga AS; Arasaradnam RP; Covington JA
Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821653
[TBL] [Abstract][Full Text] [Related]
20. Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging.
Shkolyar E; Zhao Q; Mach KE; Teslovich NC; Lee TJ; Cox S; Skinner EC; Lu Y; Liao JC
Urol Oncol; 2021 Aug; 39(8):497.e9-497.e15. PubMed ID: 33766467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
